Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial. / Jensen, Nicole Jacqueline; Wodschow, Helena Zander; Skytte, Mads Juul; Samkani, Amirsalar; Astrup, Arne; Frystyk, Jan; Hartmann, Bolette; Holst, Jens Juul; Larsen, Thomas Meinert; Madsbad, Sten; Magkos, Faidon; Miskowiak, Kamilla Woznica; Haugaard, Steen Bendix; Krarup, Thure; Rungby, Jørgen; Thomsen, Mads Norvin.

In: Clinical Nutrition, Vol. 41, No. 7, 2022, p. 1605-1612.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jensen, NJ, Wodschow, HZ, Skytte, MJ, Samkani, A, Astrup, A, Frystyk, J, Hartmann, B, Holst, JJ, Larsen, TM, Madsbad, S, Magkos, F, Miskowiak, KW, Haugaard, SB, Krarup, T, Rungby, J & Thomsen, MN 2022, 'Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial', Clinical Nutrition, vol. 41, no. 7, pp. 1605-1612. https://doi.org/10.1016/j.clnu.2022.05.005

APA

Jensen, N. J., Wodschow, H. Z., Skytte, M. J., Samkani, A., Astrup, A., Frystyk, J., Hartmann, B., Holst, J. J., Larsen, T. M., Madsbad, S., Magkos, F., Miskowiak, K. W., Haugaard, S. B., Krarup, T., Rungby, J., & Thomsen, M. N. (2022). Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial. Clinical Nutrition, 41(7), 1605-1612. https://doi.org/10.1016/j.clnu.2022.05.005

Vancouver

Jensen NJ, Wodschow HZ, Skytte MJ, Samkani A, Astrup A, Frystyk J et al. Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial. Clinical Nutrition. 2022;41(7):1605-1612. https://doi.org/10.1016/j.clnu.2022.05.005

Author

Jensen, Nicole Jacqueline ; Wodschow, Helena Zander ; Skytte, Mads Juul ; Samkani, Amirsalar ; Astrup, Arne ; Frystyk, Jan ; Hartmann, Bolette ; Holst, Jens Juul ; Larsen, Thomas Meinert ; Madsbad, Sten ; Magkos, Faidon ; Miskowiak, Kamilla Woznica ; Haugaard, Steen Bendix ; Krarup, Thure ; Rungby, Jørgen ; Thomsen, Mads Norvin. / Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial. In: Clinical Nutrition. 2022 ; Vol. 41, No. 7. pp. 1605-1612.

Bibtex

@article{7b4cd68f9f8140c396e315b26c7757dd,
title = "Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial",
abstract = "Background & aims: We evaluated the effect of weight loss induced by dietary carbohydrate restriction on health-related quality of life (HRQoL) and cognition in type 2 diabetes (T2D).Methods: In this randomised parallel trial, 72 adults with T2D and overweight/obesity (mean ± SD, HbA1c: 57 ± 8 mmol/mol and BMI: 33 ± 5 kg/m2) were randomly assigned to a carbohydrate-reduced high-protein diet (CRHP: C30E%-P30E%-F40E%) or conventional diabetes diet (CD: C50E%-P17E%-F33E%) for 6 weeks, targeting a 6% weight loss. HRQoL was assessed from the short form 36 (SF-36) questionnaire, including physical and mental component summary (PCS and MCS) scores; global cognition, verbal memory, attention and psychomotor speed, and executive function were assessed from a neuropsychological test battery.Results: Both diet groups achieved a 5.8 kg weight loss and improved PCS (median [25th;75th percentiles], CD: 2.7 [1.1; 4.2] vs. CRHP: 2.1 [0.7; 3.7]), with no difference between diets. The CRHP diet resulted in a clinically relevant improvement of MCS, albeit non-significantly different compared with the change after the CD diet (2.0 [-0.7; 4.8], p = 0.15). Global cognition, attention, and verbal memory were unaffected by the CRHP diet, which selectively worsened the Symbol Digit Modality Test assessing psychomotor speed when compared with the CD diet (-4.1 [-7.2;-1.1], p < 0.01).Conclusion: Physical health improved by weight loss independently of macronutrient distribution, while mental health and cognition may be affected by the amount of carbohydrate, protein and fat in the diet. Collectively, our data suggest that weight loss through moderate carbohydrate restriction has no clinically important impact on HRQoL and global cognition in patients with T2D. Registered under ClinicalTrials.gov Identifier no. NCT03814694.",
keywords = "Faculty of Science, Carbohydrate restriction, Cognition, Dietary intervention, Health-related quality of life, Type 2 diabetes, Weight loss",
author = "Jensen, {Nicole Jacqueline} and Wodschow, {Helena Zander} and Skytte, {Mads Juul} and Amirsalar Samkani and Arne Astrup and Jan Frystyk and Bolette Hartmann and Holst, {Jens Juul} and Larsen, {Thomas Meinert} and Sten Madsbad and Faidon Magkos and Miskowiak, {Kamilla Woznica} and Haugaard, {Steen Bendix} and Thure Krarup and J{\o}rgen Rungby and Thomsen, {Mads Norvin}",
note = "Copyright {\textcopyright} 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2022",
doi = "10.1016/j.clnu.2022.05.005",
language = "English",
volume = "41",
pages = "1605--1612",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Elsevier",
number = "7",

}

RIS

TY - JOUR

T1 - Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial

AU - Jensen, Nicole Jacqueline

AU - Wodschow, Helena Zander

AU - Skytte, Mads Juul

AU - Samkani, Amirsalar

AU - Astrup, Arne

AU - Frystyk, Jan

AU - Hartmann, Bolette

AU - Holst, Jens Juul

AU - Larsen, Thomas Meinert

AU - Madsbad, Sten

AU - Magkos, Faidon

AU - Miskowiak, Kamilla Woznica

AU - Haugaard, Steen Bendix

AU - Krarup, Thure

AU - Rungby, Jørgen

AU - Thomsen, Mads Norvin

N1 - Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

PY - 2022

Y1 - 2022

N2 - Background & aims: We evaluated the effect of weight loss induced by dietary carbohydrate restriction on health-related quality of life (HRQoL) and cognition in type 2 diabetes (T2D).Methods: In this randomised parallel trial, 72 adults with T2D and overweight/obesity (mean ± SD, HbA1c: 57 ± 8 mmol/mol and BMI: 33 ± 5 kg/m2) were randomly assigned to a carbohydrate-reduced high-protein diet (CRHP: C30E%-P30E%-F40E%) or conventional diabetes diet (CD: C50E%-P17E%-F33E%) for 6 weeks, targeting a 6% weight loss. HRQoL was assessed from the short form 36 (SF-36) questionnaire, including physical and mental component summary (PCS and MCS) scores; global cognition, verbal memory, attention and psychomotor speed, and executive function were assessed from a neuropsychological test battery.Results: Both diet groups achieved a 5.8 kg weight loss and improved PCS (median [25th;75th percentiles], CD: 2.7 [1.1; 4.2] vs. CRHP: 2.1 [0.7; 3.7]), with no difference between diets. The CRHP diet resulted in a clinically relevant improvement of MCS, albeit non-significantly different compared with the change after the CD diet (2.0 [-0.7; 4.8], p = 0.15). Global cognition, attention, and verbal memory were unaffected by the CRHP diet, which selectively worsened the Symbol Digit Modality Test assessing psychomotor speed when compared with the CD diet (-4.1 [-7.2;-1.1], p < 0.01).Conclusion: Physical health improved by weight loss independently of macronutrient distribution, while mental health and cognition may be affected by the amount of carbohydrate, protein and fat in the diet. Collectively, our data suggest that weight loss through moderate carbohydrate restriction has no clinically important impact on HRQoL and global cognition in patients with T2D. Registered under ClinicalTrials.gov Identifier no. NCT03814694.

AB - Background & aims: We evaluated the effect of weight loss induced by dietary carbohydrate restriction on health-related quality of life (HRQoL) and cognition in type 2 diabetes (T2D).Methods: In this randomised parallel trial, 72 adults with T2D and overweight/obesity (mean ± SD, HbA1c: 57 ± 8 mmol/mol and BMI: 33 ± 5 kg/m2) were randomly assigned to a carbohydrate-reduced high-protein diet (CRHP: C30E%-P30E%-F40E%) or conventional diabetes diet (CD: C50E%-P17E%-F33E%) for 6 weeks, targeting a 6% weight loss. HRQoL was assessed from the short form 36 (SF-36) questionnaire, including physical and mental component summary (PCS and MCS) scores; global cognition, verbal memory, attention and psychomotor speed, and executive function were assessed from a neuropsychological test battery.Results: Both diet groups achieved a 5.8 kg weight loss and improved PCS (median [25th;75th percentiles], CD: 2.7 [1.1; 4.2] vs. CRHP: 2.1 [0.7; 3.7]), with no difference between diets. The CRHP diet resulted in a clinically relevant improvement of MCS, albeit non-significantly different compared with the change after the CD diet (2.0 [-0.7; 4.8], p = 0.15). Global cognition, attention, and verbal memory were unaffected by the CRHP diet, which selectively worsened the Symbol Digit Modality Test assessing psychomotor speed when compared with the CD diet (-4.1 [-7.2;-1.1], p < 0.01).Conclusion: Physical health improved by weight loss independently of macronutrient distribution, while mental health and cognition may be affected by the amount of carbohydrate, protein and fat in the diet. Collectively, our data suggest that weight loss through moderate carbohydrate restriction has no clinically important impact on HRQoL and global cognition in patients with T2D. Registered under ClinicalTrials.gov Identifier no. NCT03814694.

KW - Faculty of Science

KW - Carbohydrate restriction

KW - Cognition

KW - Dietary intervention

KW - Health-related quality of life

KW - Type 2 diabetes

KW - Weight loss

U2 - 10.1016/j.clnu.2022.05.005

DO - 10.1016/j.clnu.2022.05.005

M3 - Journal article

C2 - 35679680

VL - 41

SP - 1605

EP - 1612

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 7

ER -

ID: 310219421